Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2015 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology

PALATINE, IL--(Marketwired - December 17, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that's it is...
November 10, 2015 06:00 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Receives 2015 Frost & Sullivan North American Opioid Oral Abuse Deterrence Technology Innovation Award

PALATINE, IL--(Marketwired - November 10, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse-deterrent drugs, announced that it received the 2015...
November 04, 2015 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Third Quarter 2015 Financial Results

PALATINE, IL--(Marketwired - November 04, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
October 28, 2015 06:30 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host Third Quarter 2015 Financial Results Conference Call on November 5, 2015

PALATINE, IL--(Marketwired - October 28, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
October 12, 2015 06:30 ET | Source: Acura Pharmaceuticals, Inc.

Acura Receives $2.5 Million Milestone Payment From Egalet Corporation

PALATINE, IL--(Marketwired - October 12, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced the receipt of a $2.5 million milestone payment from Egalet Corporation (NASDAQ: EGLT)...
September 16, 2015 16:10 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Meets NASDAQ's Continuing Listing Requirement

PALATINE, IL--(Marketwired - September 16, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) (the "Company"), announced that on September 15, 2015, the Company received a letter from the Listing...
September 09, 2015 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Egalet Corporation Launches Acura Pharmaceuticals' OXAYDO(TM)

PALATINE, IL--(Marketwired - September 09, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), today announced that Egalet Corporation (NASDAQ: EGLT) has commercially launched in the United States...
August 24, 2015 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces 1-for-5 Reverse Stock Split

PALATINE, IL--(Marketwired - August 24, 2015) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) (the "Company"), announced today that it will effect a 1-for-5 reverse stock split of its common stock. At a...
August 03, 2015 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Second Quarter 2015 Financial Results

PALATINE, IL--(Marketwired - August 03, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse,...
July 27, 2015 10:11 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call on August 4, 2015

PALATINE, IL--(Marketwired - July 27, 2015) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company plans to...